Literature DB >> 16416313

Variation in the lipoprotein lipase gene influences exercise-induced left ventricular growth.

David M Flavell1, Peter T E Wootton, Saul G Myerson, Michael J World, Dudley J Pennell, Steve E Humphries, Philippa J Talmud, Hugh E Montgomery.   

Abstract

The adult heart relies predominantly on fatty acids (FA) for energy generation, and defects in FA catabolism cause dramatic left ventricular (LV) growth in early age. Since lipoprotein lipase (LPL) is the key enzyme in plasma triglyceride catabolism and is highly expressed in the myocardium, we investigated an association between the functional LPL gene serine 447 stop (S447X) variant and exercise-induced LV growth. The S447X variant was genotyped in 146 British Army recruits undergoing a 10-week exercise programme. Over the training period, X447 allele carriers showed less LV growth than S447 homozygotes (SS, 5.8+/-0.7%; SX, 2.2+/-1.5%; P=0.03) and a decrease in systolic blood pressure (DeltaSBP: SS, 1.9+/-1.3 mmHg; SX, -5.7+/-2.2 mmHg; P=0.015). Although LPL genotype did not significantly predict LV growth with DeltaSBP in statistical modelling (LPL, P=0.14; DeltaSBP, P=0.06), regression analysis indicated that LPL S447X genotype effect on DeltaSBP accounted for only 20% of the effect on LV growth. In multivariate analysis, LPL, peroxisome-proliferator-activated receptor alpha and angiotensin-converting enzyme genotypes were independent predictors of cardiac growth. Thus, LPL S447X genotype influenced exercise-induced changes in LV mass and SBP. Change in blood pressure accounted for a proportion of LV growth. These data suggest that increased myocardial FA availability may reduce exercise-induced LV growth.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16416313     DOI: 10.1007/s00109-005-0002-8

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  41 in total

Review 1.  The use of partial fatty acid oxidation inhibitors for metabolic therapy of angina pectoris and heart failure.

Authors:  Heinz Rupp; Angel Zarain-Herzberg; Bernhard Maisch
Journal:  Herz       Date:  2002-11       Impact factor: 1.443

2.  Lipoprotein lipase gene variation is associated with a paternal history of premature coronary artery disease and fasting and postprandial plasma triglycerides: the European Atherosclerosis Research Study (EARS).

Authors:  S E Humphries; V Nicaud; J Margalef; L Tiret; P J Talmud
Journal:  Arterioscler Thromb Vasc Biol       Date:  1998-04       Impact factor: 8.311

3.  Left ventricular hypertrophy with exercise and ACE gene insertion/deletion polymorphism: a randomized controlled trial with losartan.

Authors:  S G Myerson; H E Montgomery; M Whittingham; M Jubb; M J World; S E Humphries; D J Pennell
Journal:  Circulation       Date:  2001-01-16       Impact factor: 29.690

4.  Lipoprotein lipase mutations, plasma lipids and lipoproteins, and risk of ischemic heart disease. A meta-analysis.

Authors:  H H Wittrup; A Tybjaerg-Hansen; B G Nordestgaard
Journal:  Circulation       Date:  1999-06-08       Impact factor: 29.690

5.  Bradykinin B2BKR receptor polymorphism and left-ventricular growth response.

Authors:  D Brull; S Dhamrait; S Myerson; J Erdmann; D Woods; M World; D Pennell; S Humphries; V Regitz-Zagrosek; H Montgomery
Journal:  Lancet       Date:  2001-10-06       Impact factor: 79.321

6.  Peroxisome proliferator--activated receptor alpha gene regulates left ventricular growth in response to exercise and hypertension.

Authors:  Yalda Jamshidi; Hugh E Montgomery; Hans-Werner Hense; Saul G Myerson; Ines Pineda Torra; Bart Staels; Michael J World; Angela Doering; Jeanette Erdmann; Christian Hengstenberg; Steve E Humphries; Heribert Schunkert; David M Flavell
Journal:  Circulation       Date:  2002-02-26       Impact factor: 29.690

7.  Effect of increased afterload on cardiac lipoprotein lipase and VLDL receptor expression.

Authors:  N D Vaziri; K Liang; C H Barton
Journal:  Biochim Biophys Acta       Date:  1999-01-04

Review 8.  Molecular mechanisms of inherited cardiomyopathies.

Authors:  Diane Fatkin; Robert M Graham
Journal:  Physiol Rev       Date:  2002-10       Impact factor: 37.312

9.  Regulation of very-low-density lipoprotein receptor in hypertrophic rat heart.

Authors:  H Masuzaki; H Jingami; N Matsuoka; O Nakagawa; Y Ogawa; M Mizuno; Y Yoshimasa; T Yamamoto; K Nakao
Journal:  Circ Res       Date:  1996-01       Impact factor: 17.367

10.  Electrophoresis for genotyping: microtiter array diagonal gel electrophoresis on horizontal polyacrylamide gels, hydrolink, or agarose.

Authors:  I N Day; S E Humphries
Journal:  Anal Biochem       Date:  1994-11-01       Impact factor: 3.365

View more
  3 in total

1.  Lipoprotein lipase and heart size.

Authors:  F C Luft
Journal:  J Mol Med (Berl)       Date:  2006-01-17       Impact factor: 4.599

2.  DGAT1 expression increases heart triglyceride content but ameliorates lipotoxicity.

Authors:  Li Liu; XiaoJing Shi; Kalyani G Bharadwaj; Shota Ikeda; Haruyo Yamashita; Hiroaki Yagyu; Jean E Schaffer; Yi-Hao Yu; Ira J Goldberg
Journal:  J Biol Chem       Date:  2009-09-24       Impact factor: 5.157

3.  Deep-targeted sequencing of endothelial nitric oxide synthase gene exons uncovers exercise intensity and ethnicity-dependent associations with post-exercise hypotension.

Authors:  Linda S Pescatello; Elizabeth D Schifano; Garrett I Ash; Gregory A Panza; Lauren M L Corso; Ming-Hui Chen; Ved Deshpande; Amanda Zaleski; Burak Cilhoroz; Paulo Farinatti; Beth A Taylor; Rachel J O'Neill; Paul D Thompson
Journal:  Physiol Rep       Date:  2017-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.